← All trials
NCT01644721
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2012
- Primary completion
- Dec 1, 2015
- Completion date
- May 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 3750
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Bandim Health ProjectLead sponsor
- Bandim Health ProjectOverall official - principal investigator
- Bandim Health ProjectStudy director
- Navrongo Health Research Centre, GhanaCollaborator
- University of HeidelbergCollaborator
- Centre de Recherche en Sante de Nouna, Burkina FasoCollaborator
- National Institute for Public Health and the Environment, RIVM, HollandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.